NOUGUES MAXIMO F (Chief Financial Officer) sold 5.4% of their position (10.95K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $64.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/8/2026ACC: 0001437749-26-000921
Officer· Chief Financial Officer
Since Nov 2018
-10.95K
Net shares
Net seller
$64.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.54K
Price / share
$5.84
Trade value
$26.53K
% of position
2.2%
1/6/2026
204.23K→199.69K
Common Stock
Direct
Shares
−6.41K
Price / share
$5.88
Trade value
$37.65K
% of position
3.2%
1/7/2026
199.69K→193.28K
Total
Net shares
−10.95K
Net value
-$64.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | S · Sale | −4.54K | $5.84 | $26.53K | 2.2% | 204.23K | 199.69K |
| Common Stock Direct | 1/7/2026 | S · Sale | −6.41K | $5.88 | $37.65K | 3.2% | 199.69K | 193.28K |
| Total | −10.95K | -$64.19K | ||||||
Derivative Transactions0
No derivative transactions reported